HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin.

AbstractBackground:
Postthrombotic syndrome (PTS) is a long-term complication after deep vein thrombosis (DVT) and can affect quality of life (QoL). Pathogenesis is not fully understood but inadequate anticoagulant therapy with vitamin K antagonists is a known risk factor for the development of PTS.
Objectives:
To compare the prevalence of PTS after acute DVT and the long-term QoL following DVT between patients treated with edoxaban or warfarin.
Methods:
We performed a long-term follow-up study in a subset of patients with DVT who participated in the Hokusai-VTE trial between 2010 and 2012 (NCT00986154). Primary outcome was the prevalence of PTS, defined by the Villalta score. The secondary outcome was QoL, assessed by validated disease-specific (VEINES-QOL) and generic health-related (SF-36) questionnaires.
Results:
Between 2017 and 2020, 316 patients were enrolled in 26 centers in eight countries, of which 168 (53%) patients had been assigned to edoxaban and 148 (47%) to warfarin during the Hokusai-VTE trial. Clinical, demographic, and thrombus-specific characteristics were comparable for both groups. Mean (SD) time since randomization in the Hokusai-VTE trial was 7.0 (1.0) years. PTS was diagnosed in 85 (51%) patients treated with edoxaban and 62 (42%) patients treated with warfarin (adjusted odds ratio 1.6, 95% CI 1.0-2.6). Mean differences in QoL scores between treatment groups were not clinically relevant.
Conclusion:
Contrary to our hypothesis, the prevalence of PTS tended to be higher in patients treated with edoxaban compared with warfarin. No differences in QoL were observed. Further research is warranted to unravel the role of anticoagulant therapy on development of PTS.
AuthorsIngrid M Bistervels, Roisin Bavalia, Jan Beyer-Westendorf, Arina J Ten Cate-Hoek, Sebastian M Schellong, Michael J Kovacs, Nicolas Falvo, Karina Meijer, Dominique Stephan, Wim G Boersma, Marije Ten Wolde, Francis Couturaud, Peter Verhamme, Dominique Brisot, Susan R Kahn, Waleed Ghanima, Karine Montaclair, Amanda Hugman, Patrick Carroll, Gilles Pernod, Olivier Sanchez, Emile Ferrari, Pierre-Marie Roy, Marie-Antoinette Sevestre-Pietri, Simone Birocchi, Hilde S Wik, Barbara A Hutten, Michiel Coppens, Christiane Naue, Michael A Grosso, Minggao Shi, Yong Lin, Isabelle Quéré, Saskia Middeldorp, Hokusai PTS Investigators
JournalResearch and practice in thrombosis and haemostasis (Res Pract Thromb Haemost) Vol. 6 Issue 5 Pg. e12748 (Jul 2022) ISSN: 2475-0379 [Electronic] United States
PMID35992565 (Publication Type: Journal Article)
Copyright© 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: